A group of researchers led by Leif Schroeder from the Leibniz-Forschungsinstitut fuer Molekulare Pharmakologie (FMP) have found a way to detect metastases in certain types of cancer in the brain at an ...

A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between ...

An "Original Research" article published in ARRS' American Journal of Roentgenology (AJR) concluded that the accuracy of breast cancer diagnosis via diffusion-tensor imaging (DTI) was equivalent both ...

A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between ...

Magnetic resonance imaging (MRI) visualizes internal body structures, often with the help of contrast agents to enhance sensitivity. Scientists have now developed a bimodal contrast agent suited for ...

In a possible first, researchers at Stanford (Calif.) Medicine found a non-invasive imaging method to visualize senescent cells. “As we age, we accumulate senescent cells. These are like ‘zombie cells ...

Scientists at the Institute of Chemistry have developed a new type of contrast agent for magnetic resonance imaging (MRI)—bovine serum albumin nanoparticles doped with manganese (II) ions. The results ...

Compared to group I GBCAs, group II GBCAs appear safe for use in patients with severe kidney disease. In a recent analysis, the risk of NSF in patients with stage 4 or 5 CKD was less than 0.07% with ...